Identification of sentinel lymph node in breast cancer by lymphoscintigraphy and surgical gamma probe with peritumoral injection of scintimammographic agent "99mTc MIBI"

Annals of Nuclear Medicine

Volumn 16, Issue 2, 2002, Pages 121-126

  Aras, G ^a   Arican, P ^a   Cam R ^a   Kucuk N O ^a   Ibis E ^a   Tuzuner A ^a   Soylu, A ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

99mTc MIBI; Breast cancer; Lymphoscintigraphy; Sentinel lymph node; Surgical gamma probe

Indexed keywords

DYE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; COLORING AGENT; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; APPARATUS; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DEVICE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; EVALUATION; FEMALE; GAMMA IRRADIATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMAGE ENHANCEMENT; INJECTION SITE; INTRAOPERATIVE PERIOD; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MASTECTOMY; PRIORITY JOURNAL; SENTINEL LYMPH NODE; AGED; AXILLA; BREAST TUMOR; INTRALESIONAL DRUG ADMINISTRATION; LYMPHADENECTOMY; METASTASIS; MIDDLE AGED; SCINTISCANNING; SENTINEL LYMPH NODE BIOPSY;

ADULT; AGED; AXILLA; BREAST NEOPLASMS; DYES; FEMALE; HUMAN; INJECTIONS, INTRALESIONAL; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MIDDLE AGE; RADIOPHARMACEUTICALS; SENTINEL LYMPH NODE BIOPSY; TECHNETIUM TC 99M SESTAMIBI; COLORING AGENTS; HUMANS; MIDDLE AGED;

EID: 0036001347     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02993715     Document Type: Article

References (45)

1. The results of operations for the cure of cancer of the breast performed at the Johns Hopkins Hospital from June 1989 to January 1994
2. Patients with early breast cancer benefit from effective axillary treatment
3. Natural history of breast cancer
4. Distribution of axillary node metastases by level of invasion. An analysis of 539 cases
5. Complete axillary lymph node dissection for stage I-II carcinoma of the breast
6. Level I and II axillary dissection in the treatment of early-stage breast cancer: An analysis of 259 consecutive patients
7. Total axillary lymphadenectomy in the management of breast cancer
8. The inadequacy of axillary sampling in breast cancer
9. Assessment of axillary lymph node status
10. Edema of the arm as a function of the extent of axillary surgery in patients with Stage I-II carcinoma of the breast treated with primary radiotherapy
11. Influence of adjuvant irradiation on the development of late arm lymphedema and impaired shoulder mobility after mastectomy for carcinoma of the breast
12. Assessment of morbidity from complete axillary dissection
13. Sentinel node biopsy in breast cancer
14. Sentinel-lymph-node in breast cancer
15. The sentinel node in breast cancer: Implications for adjuvant treatment?
16. Intradermal blue dye to identify sentinel lymph node in breast cancer
17. Sentinel node localization in patients with breast cancer
18. Mammary lymphoscintigraphy in breast cancer
19. Lymphoscintigraphy, techniques and application in the management of breast carcinoma
20. Lymphoscintigraphy for locating the sentinel lymph node in patients with breast cancer
21. Identification and biopsy of the sentinel node in breast cancer
22. Surgical resection and radiolocalization of sentinel lymph node in breast cancer using a gamma probe
23. Sentinel lymph node biopsy in breast cancer: Guidelines and pitfalls of lymphoscintigraphy and gamma probe detection
24. 99mTc Sestamibi prone breast imaging for the diagnosis of breast carcinoma
25. 99mTc MIBI: A comparative study with mammography and ultrasonography
26. 99mTc methoxy-butylisonitrile breast scintigraphy to evaluate palpable breast masses
27. Prone scintimammography in patients with non-palpable breast lesions
28. 99mTc MIBI scintimammography for suspicious breast lesions
29. Scintimammography: The new role of Technetium-99m Sestamibi imaging for the diagnosis of breast carcinoma
30. 99mTechnetium Sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement
31. 99mTc MIBI breast scintigraphy ultra-sound and conventional mammography
32. Detection of lymph node metastases by lymphoscintigraphy with a tumour-seeking tracer in breast cancer patients
33. The value of pre-operative lymphoscintigraphy in breast cancer treatment
34. Lymphoscintigraphy and Radioguided Biopsy of the Sentinel axillary node in breast cancer
35. Mapping sentinel lymph node in breast cancer by combined lymphoscintigraphy, blue dye, and intraoperative gamma probe
36. Sentinel lymphadenectomy in primary breast carcinoma: An alternative to routine axillary dissection
37. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer
38. Lymphatic mapping and sentinel lymph node biopsy in breast cancer
39. Sentinel node biopsy in 70 unselected patients with breast cancer: Increased feasibility by using 10 mCi radiocolloid in combination with a blue dye tracer
40. Lymphoscintigraphy: Radiopharmaceutical Selection and Methods
41. Lymphatic mapping and sentinel node biopsy in the patients with breast cancer
42. Sentinel node imaging and biopsy in breast cancer patients
43. Sentinel lymph node mapping in breast cancer using subareolar injection of blue dye
44. Value of macroscopic analysis for identification of axillary sentinel nodes detected by potent blue dye alone during breast cancer surgery
45. Sentinel node localization in breast cancer patients using intradermal dye injection